Forbes
@forbes·2.1M subscribers·11.3K videos
Regeneron CEO On The Eye Drug Market | Forbes
Posted
August 14, 2013
Views
1,917
Likes
10
Comments
1
Engagement
0.57%
August 14, 2013
1,917
10
1
0.57%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:00Now PlayingEylea, for macular degeneration, was Regeneron's first big hit. Can sales keep up?
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
